Cite

HARVARD Citation

    Kim, Y. et al. (2018). XANAP: A real‐world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia. Journal of arrhythmia. 34 (4), pp. 418-427. [Online]. 
  
Back to record